JY
AEMD icon

Jeff Yass’s Aethlon Medical AEMD Stock Holding History

Jeff Yass’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed -$15K – 12784
2022
Q1 		$15K Sell
3
-6
-67% -$35.8K ﹤0.01% 12687
2021
Q4 		$70K Sell
9
-3
-25% -$34.2K ﹤0.01% 12375
2021
Q3 		$183K Buy
12
+8
+200% +$134K ﹤0.01% 11592
2021
Q2 		$74K Buy
+4
New +$46.1K ﹤0.01% 12200

Other funds holding AEMD

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jeff Yass's AEMD Position: Q3 2024 in Review

Jeff Yass sold out of Aethlon Medical (AEMD) in Q3 2024, closing a stake of 92 shares — an estimated $18.3K sold.

Jeff Yass first reported a position in AEMD in Q2 2018 and held it in 7 quarters. The position peaked at $66K in Q2 2018. 12 funds tracked by Wall St. Rank hold AEMD as of Q3 2024.

  • Jeff Yass reported no remaining Aethlon Medical position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 92 Aethlon Medical shares in Q3 2024, an estimated $18.3K.
  • Jeff Yass first reported a position in Aethlon Medical in Q2 2018 and held it in 7 quarters.
  • Jeff Yass's Aethlon Medical position peaked at $66K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.